Covidien
Covidien Receives FDA Approval for Oral Transmucosal Fentanyl Citrate Product
Published in Medical Devices and Surgical Technology Week, November 22nd, 2009
Covidien's product is a generic alternative to the branded ACTIQ®. It is a solid formulation of fentanyl that resembles a lozenge on a handle. Oral Transmucosal Fentanyl Citrate, a Class II controlled substance, is an opioid analgesic indicated only for the management of breakthrough cancer pain in patients 16 years of age and older with malignancies who are already receiving and who are...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- European Society of Cardiology
US and Europe different in aldosterone antagonists use in heart failure - University of Bonn
New therapy gives hope for very severe depression - University of Texas M. D. Anderson Cancer Center
Green tea shows promise as chemoprevention agent for oral cancer, M. D. Anderson study finds - Arrhythmia
New Research Uncovers Potential Dangers of Portable Headphones on Life-Saving Cardiac Devices - CareFusion Corporation
CareFusion Reports First Quarter Results, Raises Full-Year Outlook - Cataract
New Data Show Blue Light-Filtering Intraocular Lens Implantation During Cataract Surgery Increases Nutritional Component of the Eye, Which May Offer Protection Against Age-Related Vision Loss - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
